Detalhe da pesquisa
1.
Management of Multidrug-Resistant Tuberculosis.
Semin Respir Crit Care Med
; 39(3): 310-324, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30071546
2.
Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil.
Eur Respir J
; 49(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331044
3.
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
Eur Respir J
; 49(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529205
4.
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Eur Respir J
; 47(4): 1235-43, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26965290
5.
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Eur Respir J
; 47(6): 1758-66, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076583
6.
Multidrug-resistant tuberculosis.
Lancet
; 394(10195): 298, 2019 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31354137
7.
The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines.
Eur Respir J
; 54(4)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601719
8.
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
Eur Respir J
; 44(1): 23-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24659544
9.
Management of multidrug resistant tuberculosis.
Semin Respir Crit Care Med
; 34(1): 44-59, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23460005
10.
Bedaquiline: how better to use it.
Eur Respir J
; 50(5)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29122921
11.
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.
Eur Respir J
; 50(1)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679614
12.
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Eur Respir J
; 40(6): 1430-42, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22496332
13.
A predictive scoring instrument for tuberculosis lost to follow-up outcome.
Respir Res
; 13: 75, 2012 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22938040
14.
Treatment interruption patterns and adverse events among patients on bedaquiline containing regimen under programmatic conditions in India.
Pulmonology
; 28(3): 203-209, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121945
15.
Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools.
Arch Bronconeumol
; 58(12): 809-820, 2022 Dec.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35945071
16.
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.
Clin Infect Dis
; 62(9): 1188-90, 2016 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908794
17.
Efficacy and tolerability of ethionamide versus prothionamide: a systematic review.
Eur Respir J
; 48(3): 946-52, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27288034
18.
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.
Eur Respir J
; 48(3): 938-43, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338197
19.
Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.
Eur Respir J
; 48(5): 1503-1507, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587544
20.
Automated Digital Microscopy in New Tuberculosis Diagnostic Algorithms. Can It Boost Case Finding?
Am J Respir Crit Care Med
; 191(12): 1352-3, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26075421